Evidence map›Paper›PMID 38939458›Full record

ArticleJACC. Advances2022

Prognostic Value of the H

Alexander C Egbe, William R Miranda, Yogesh N V Reddy, Jason H Anderson, Kartik Andi, Ahmed Goda, Omar Abozied, Heidi M Connolly, Barry A Borlaug

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexander C EgbeDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
William R MirandaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Yogesh N V ReddyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jason H AndersonDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Kartik AndiDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ahmed GodaDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Omar AboziedDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Heidi M ConnollyDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Barry A BorlaugDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Risk stratification is challenging in adults with repaired coarctation of aorta (COA) because of the complex interaction of multiple hemodynamic factors and differences in left ventricular adaptation to these factors. The H Objectives: The purpose of this study was to assess the prognostic role of the H Methods: This is a retrospective cohort study of adults with repaired COA at the Mayo Clinic (2003-2019). The H Results: We identified 712 patients (age 33 years [range 21-45 years]; 419 [59%] males). The baseline H Conclusions: These results suggest that the H

Indexed as

heart failuremortalityprognostication

Identifiers

PMID38939458
PMCPMC11198562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.